QDEL — Quidelortho News Story

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
$953.88m
Enterprise Value
$3.72bn
Revenue
$2.73bn

All News

Brief: Quidelortho And Bühlmann Laboratories AG Announce Availability Of Fecal Calprotectin (Fcal®) Turbo And Fecal Pancreatic Elastase (Fpela®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa)

Quidelortho

14/07/2025 12:18

Quidelortho Corp QDEL.O:

QUIDELORTHO AND BĂśHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCALÂ®) TURBO AND FECAL PANCREATIC ELASTASE (FPELAÂ®) TURBO ASSAYS ON VITROSâ„˘ SYSTEMS AS A MICROTIPâ„˘ PARTNERSHIP ASSAY (MPA)

Source text: ID:nPn9xQXyqa

Further company coverage: QDEL.O

QDEL — Quidelortho News Story

Brief: Quidelortho And Bühlmann Laboratories AG Announce Availability Of Fecal Calprotectin (Fcal®) Turbo And Fecal Pancreatic Elastase (Fpela®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa)

Recent news on Quidelortho

Brief: Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026

QuidelOrtho Corp reports results for the quarter ended June 30 - Earnings Summary

Brief: QuidelOrtho Q2 EPS USD -1.36

Media: QuidelOrtho looks to sell testing unit as PE circles healthcare companies - FT

U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras